Balance Sheet Bastide Le Confort Médical

Stocks

BLC

FR0000035370

Healthcare Facilities & Services

Market Closed - Euronext Paris Other stock markets 09:25:00 10/07/2026 pm IST			5-day change	1st Jan Change
23.35 ^EUR	+0.21%		-3.71%	-2.71%

02/06	Bastide finalizes the sale of its EXPERF subsidiary
02/06	France's Groupe Bastide Completes Sale of New Medical Concept Subsidiary	MT

b1cc1.5JblHaI1JX87CeF7PgjIoQUJQzQxtdFWidvOkVZ7E40.i9ucbsZ2YSVSbpEuZF6L-1drN3hm3JI90-2v4wApZc-U-oR4w1d_CQ07hg

Published financial data: BASTIDE LE CONFORT MÉDICAL

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	44Cr	47Cr	51Cr	53Cr	49Cr
Total Revenues	44Cr	47Cr	51Cr	53Cr	49Cr
Cost of Goods Sold, Total	16Cr	16Cr	17Cr	18Cr	16Cr
Gross Profit	28Cr	31Cr	33Cr	35Cr	33Cr
Selling General & Admin Expenses, Total	19Cr	21Cr	23Cr	24Cr	23Cr
Depreciation & Amortization - (IS)	5.08Cr	5.6Cr	5.88Cr	-	-
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	6.33Cr	5.9Cr
Other Operating Expenses	30.05L	44L	24.34L	26.1L	29.56L
Other Operating Expenses, Total	24Cr	27Cr	29Cr	31Cr	29Cr
Operating Income	3.75Cr	3.89Cr	4.28Cr	4.42Cr	4.52Cr
Interest Expense, Total	-89.05L	-1.02Cr	-1.66Cr	-2.74Cr	-3.08Cr
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-89.05L	-1.02Cr	-1.66Cr	-2.74Cr	-3.08Cr
Income (Loss) On Equity Invest.	-	10T	38T	-	28T
Other Non Operating Income (Expenses)	8L	-13.37L	26.63L	49.53L	21.89L
EBT, Excl. Unusual Items	2.94Cr	2.74Cr	2.89Cr	2.18Cr	1.66Cr
Restructuring Charges	-11.92L	-10.79L	-9L	-	-9L
Merger & Related Restructuring Charges	-2L	-8L	-3L	-	10L
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-5L	-44T	-32T	7L	-10L
Legal Settlements	-5L	-13.27L	-12.81L	-	-31.55L
Other Unusual Items	-67.73L	-31.72L	-35.56L	-59.99L	-20.32L
EBT, Incl. Unusual Items	2.02Cr	2.1Cr	2.28Cr	1.65Cr	1.05Cr
Income Tax Expense	58.22L	59.28L	59.6L	70.15L	64.92L
Earnings From Continuing Operations	1.43Cr	1.51Cr	1.68Cr	94.88L	40.47L
Earnings Of Discontinued Operations	-	-8L	-40.19L	-82.81L	-24.88L
Net Income to Company	1.43Cr	1.43Cr	1.28Cr	12.07L	15.59L
Minority Interest	-9L	-6L	-7L	-21.07L	-10.31L
Net Income - (IS)	1.35Cr	1.37Cr	1.2Cr	-9L	5L
Net Income to Common Incl Extra Items	1.35Cr	1.37Cr	1.2Cr	-9L	5L
Net Income to Common Excl. Extra Items	1.35Cr	1.44Cr	1.61Cr	73.81L	30.16L
Per Share Items
Net EPS - Basic	1.83	1.86	1.62	-0.12	0.07
Basic EPS - Continuing Operations	1.83	1.96	2.15	0.99	0.4
Basic Weighted Average Shares Outstanding	73.48L	73.51L	74.57L	74.6L	74.69L
Net EPS - Diluted	1.83	1.86	1.52	-0.11	0.07
Diluted EPS - Continuing Operations	1.83	1.96	2.03	0.93	0.38
Diluted Weighted Average Shares Outstanding	73.57L	73.73L	79.38L	79.41L	79.38L
Normalized Basic EPS	2.38	2.24	2.33	1.54	1.25
Normalized Diluted EPS	2.37	2.24	2.18	1.45	1.17
Dividend Per Share	0.27	-	-	-	-
Payout Ratio	15.11	16.36	-	-6	-
Supplemental Items
EBITDA	7.1Cr	7.52Cr	8.24Cr	8.68Cr	8.31Cr
EBITA	3.78Cr	3.91Cr	4.29Cr	4.42Cr	4.52Cr
EBIT	3.75Cr	3.89Cr	4.28Cr	4.42Cr	4.52Cr
Effective Tax Rate - (Ratio)	28.87	28.21	26.18	42.51	61.6
Total Current Taxes	54.07L	36.01L	65.14L	-	38.99L
Total Deferred Taxes	4L	23.27L	-6L	-	25.93L
Normalized Net Income	1.75Cr	1.65Cr	1.73Cr	1.15Cr	93.19L
Interest on Long-Term Debt	17.58L	18.69L	20.06L	-	19.7L
Non-Cash Pension Expense	76T	5L	12T	-	2L
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	77T	62T	41T	-	-
Stock-Based Comp., Other (Total)	4L	3L	8L	-	-
Total Stock-Based Compensation	4L	3L	8L	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.37Cr	2.21Cr	3.67Cr	2.36Cr	2.55Cr
Total Cash And Short Term Investments	3.37Cr	2.21Cr	3.67Cr	2.36Cr	2.55Cr
Accounts Receivable, Total	6.85Cr	8.09Cr	8.14Cr	7.86Cr	7.93Cr
Other Receivables	1.7Cr	2.8Cr	2.66Cr	4.45Cr	3.5Cr
Total Receivables	8.54Cr	11Cr	11Cr	12Cr	11Cr
Inventory	4.29Cr	4.85Cr	4.85Cr	4.32Cr	4Cr
Other Current Assets, Total	20.61L	71.32L	32.07L	1.9Cr	9.68Cr
Total Current Assets	16Cr	19Cr	20Cr	21Cr	28Cr
Gross Property Plant And Equipment	44Cr	48Cr	53Cr	-	49Cr
Accumulated Depreciation	-24Cr	-27Cr	-32Cr	-	-30Cr
Net Property Plant And Equipment	20Cr	21Cr	21Cr	21Cr	18Cr
Long-term Investments	6L	3L	10.3L	88T	11.39L
Goodwill	18Cr	22Cr	23Cr	21Cr	18Cr
Other Intangibles, Total	71.46L	84.7L	82.12L	88.37L	99.33L
Loans Receivable Long-Term	16.22L	44.56L	63.47L	-	34.07L
Deferred Tax Assets Long-Term	37.35L	37.35L	51.9L	28.58L	13.15L
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	37.12L	36.68L	40.29L	93.38L	30.68L
Total Assets	57Cr	63Cr	66Cr	65Cr	66Cr
Liabilities
Accounts Payable, Total	6.5Cr	6.38Cr	7.31Cr	7.7Cr	7.43Cr
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	5L	69.2L	-	-	8L
Current Portion of Long-Term Debt	1.68Cr	3.23Cr	7.59Cr	4.78Cr	1.04Cr
Current Portion of Leases	1.51Cr	1.67Cr	1.64Cr	1.81Cr	1.85Cr
Other Current Liabilities	5.06Cr	5.53Cr	5.96Cr	7.33Cr	9.63Cr
Total Current Liabilities	15Cr	18Cr	22Cr	22Cr	20Cr
Long-Term Debt	25Cr	30Cr	28Cr	29Cr	34Cr
Long-Term Leases	7.17Cr	6.63Cr	5.98Cr	5.17Cr	3.82Cr
Pension & Other Post Retirement Benefits	5L	10L	-	-	10.17L
Deferred Tax Liability Non Current	20.86L	29.28L	43.23L	19.29L	10.6L
Other Non Current Liabilities	82.19L	36.78L	45.69L	54.8L	59.33L
Total Liabilities	48Cr	55Cr	57Cr	57Cr	59Cr
Common Stock, Total	33.07L	33.1L	33.56L	33.59L	33.61L
Additional Paid In Capital	94.66L	94.66L	94.66L	94.66L	94.66L
Retained Earnings	6.85Cr	7.18Cr	7.64Cr	6.85Cr	6.09Cr
Treasury Stock	-	-	-15.55L	-15.55L	-15.55L
Comprehensive Income and Other	-1T	-	-1T	-	-1T
Total Common Equity	8.13Cr	8.46Cr	8.76Cr	7.98Cr	7.21Cr
Minority Interest	37.51L	20.99L	4L	10L	-8L
Total Equity	8.51Cr	8.67Cr	8.81Cr	8.07Cr	7.13Cr
Total Liabilities And Equity	57Cr	63Cr	66Cr	65Cr	66Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	72.96L	72.84L	73.03L	74.07L	73.1L
ECS Total Common Shares Outstanding	72.96L	72.84L	73.03L	74.07L	73.1L
Book Value / Share	11.14	11.61	12	10.77	9.87
Tangible Book Value	-11Cr	-14Cr	-15Cr	-14Cr	-12Cr
Tangible Book Value Per Share	-15.07	-19.43	-20.02	-18.59	-16.39
Total Debt	36Cr	42Cr	43Cr	41Cr	41Cr
Net Debt	32Cr	40Cr	39Cr	39Cr	39Cr
Minority Interest, Total (Incl. Fin. Div)	37.51L	20.99L	4L	10L	-8L
Equity Method Investments, Total	14T	24T	62T	88T	1L
Account Code - Inventory Valuation	6	6	6	3	6
Inventories - Others	4.42Cr	5.04Cr	5.08Cr	-	4.13Cr
Land - (BS)	1L	37T	37T	-	-70T
Machinery, Total	30Cr	33Cr	36Cr	-	34Cr
Full Time Employees	3.04T	3.38T	3.64T	-	3.64T
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	19.33L	15.8L	17.79L	-	24.61L

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	1.35Cr	1.37Cr	1.2Cr	-9L	5L
Depreciation & Amortization - CF	4.88Cr	5.5Cr	5.81Cr	6.33Cr	5.75Cr
Amortization of Goodwill and Intangible Assets - (CF)	3L	1L	1L	-	42T
Depreciation & Amortization, Total	4.9Cr	5.51Cr	5.82Cr	6.33Cr	5.75Cr
Amortization of Deferred Charges, Total - (CF)	17.47L	21.03L	24.5L	-	31.25L
(Gain) Loss From Sale Of Asset	10.6L	81T	6L	-11.51L	-4L
Asset Writedown & Restructuring Costs	-1T	11.27L	6T	6T	5T
(Income) Loss On Equity Investments - (CF)	-74T	-3L	-20T	-51T	-28T
Stock-Based Compensation (CF)	4L	3L	8L	-	-
Net Cash From Discontinued Operations	-	-	44.62L	85.34L	-
Other Operating Activities, Total	99.78L	1.35Cr	1.69Cr	2.67Cr	3.59Cr
Change In Accounts Receivable	-	-	-	-	-
Change In Inventories	-	-	-	-	-
Change In Accounts Payable	-	-	-	-	-
Change in Other Net Operating Assets	-12.32L	-2.89Cr	1.02Cr	-37.7L	51.55L
Cash from Operations	7.44Cr	5.69Cr	11Cr	9.27Cr	10Cr
Capital Expenditure	-4.65Cr	-5.33Cr	-5.36Cr	-5.54Cr	-6.01Cr
Sale of Property, Plant, and Equipment	6L	26.41L	9L	41.3L	15.77L
Cash Acquisitions	-2.7Cr	-5.44Cr	-2.2Cr	96.69L	-
Divestitures	-	-	-	-	20.77L
Investment in Marketable and Equity Securities, Total	-4L	5L	-10.17L	-15.18L	1L
Net (Increase) Decrease in Loans Originated / Sold - Investing	-2L	-2L	-4L	-9L	-1L
Other Investing Activities, Total	74T	3L	-1L	3L	1T
Cash from Investing	-7.34Cr	-10Cr	-7.62Cr	-4.37Cr	-5.64Cr
Long-Term Debt Issued, Total	4.3Cr	26Cr	3.7Cr	5.69Cr	33Cr
Total Debt Issued	4.3Cr	26Cr	3.7Cr	5.69Cr	33Cr
Long-Term Debt Repaid, Total	-3.05Cr	-21Cr	-2.94Cr	-9.07Cr	-33Cr
Total Debt Repaid	-3.05Cr	-21Cr	-2.94Cr	-9.07Cr	-33Cr
Issuance of Common Stock	-	14T	48T	18T	-
Repurchase of Common Stock	-7L	-2L	-	-	-4T
Common Dividends Paid	-20.33L	-22.38L	-	-54T	-
Common & Preferred Stock Dividends Paid	-20.33L	-22.38L	-	-54T	-
Other Financing Activities, Total	-84.18L	-1.05Cr	-1.55Cr	-2.84Cr	-3.05Cr
Cash from Financing	13.4L	2.94Cr	-78.87L	-6.23Cr	-3.43Cr
Foreign Exchange Rate Adjustments	5L	91T	-37T	1L	-2L
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	28.33L	-1.81Cr	2.15Cr	-1.31Cr	1.09Cr
Supplemental Items
Cash Income Tax Paid (Refund)	85.25L	62.58L	52.29L	97.49L	45.51L
Levered Free Cash Flow	2.96Cr	-84.48L	4.27Cr	1.05Cr	-3.6Cr
Unlevered Free Cash Flow	3.52Cr	-20.7L	5.31Cr	2.76Cr	-1.67Cr
Change In Net Working Capital	-71.09L	3.07Cr	-1.85Cr	80.18L	4.55Cr
Net Debt Issued / Repaid	1.25Cr	4.24Cr	75.61L	-3.38Cr	-37.62L

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.36	4.05	4.15	4.24	4.32
Return on Total Capital	5.66	5.13	5.24	5.5	5.81
Return On Equity %	17.42	17.57	19.23	11.24	5.32
Return on Common Equity	17.14	17.41	18.66	8.82	3.97
Margin Analysis
Gross Profit Margin %	63.11	65.51	65.69	66.91	67.8
SG&A Margin	42.55	44.29	45.21	46.11	45.98
EBITDA Margin %	15.99	16.06	16.21	16.39	16.91
EBITA Margin %	8.51	8.34	8.45	8.35	9.21
EBIT Margin %	8.45	8.31	8.43	8.35	9.2
Income From Continuing Operations Margin %	3.23	3.22	3.31	1.79	0.82
Net Income Margin %	3.03	2.92	2.37	-0.17	0.11
Net Avail. For Common Margin %	3.03	3.08	3.16	1.39	0.61
Normalized Net Income Margin	3.93	3.52	3.41	2.17	1.9
Levered Free Cash Flow Margin	6.68	-1.8	8.4	1.97	-7.33
Unlevered Free Cash Flow Margin	7.93	-0.44	10.45	5.2	-3.4
Asset Turnover
Asset Turnover	0.83	0.78	0.79	0.81	0.75
Fixed Assets Turnover	2.39	2.27	2.43	2.53	2.51
Receivables Turnover (Average Receivables)	6.99	6.27	6.26	7.15	5.66
Inventory Turnover (Average Inventory)	3.35	3.54	3.6	3.82	3.8
Short Term Liquidity
Current Ratio	1.11	1.07	0.87	0.97	1.38
Quick Ratio	0.81	0.75	0.64	0.68	0.7
Operating Cash Flow to Current Liabilities	0.5	0.32	0.47	0.43	0.51
Days Sales Outstanding (Average Receivables)	52.22	58.2	58.27	51.16	64.53
Days Outstanding Inventory (Average Inventory)	108.86	103.23	101.53	95.73	95.95
Average Days Payable Outstanding	148.19	140.67	143.26	161.53	178.2
Cash Conversion Cycle (Average Days)	12.89	20.76	16.54	-14.64	-17.72
Long Term Solvency
Total Debt/Equity	420.43	483.75	485.17	506.22	576.67
Total Debt / Total Capital	80.79	82.87	82.91	83.5	85.22
LT Debt/Equity	382.46	419.19	380.42	424.56	535.11
Long-Term Debt / Total Capital	73.49	71.81	65.01	70.03	79.08
Total Liabilities / Total Assets	85.05	86.3	86.59	87.52	89.21
EBIT / Interest Expense	4.21	3.82	2.58	1.62	1.47
EBITDA / Interest Expense	9.72	9.22	6.09	3.93	3.33
(EBITDA - Capex) / Interest Expense	4.5	4	2.86	1.91	1.38
Total Debt / EBITDA	4.13	4.46	4.23	3.8	4
Net Debt / EBITDA	3.74	4.22	3.87	3.58	3.76
Total Debt / (EBITDA - Capex)	8.93	10.28	9.02	7.83	9.65
Net Debt / (EBITDA - Capex)	8.09	9.74	8.25	7.38	9.05
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.04	5.46	8.48	4.28	6.34
Gross Profit, 1 Yr. Growth %	11.39	9.47	8.78	6.21	7.9
EBITDA, 1 Yr. Growth %	6.53	3.36	3.59	4.68	10.53
EBITA, 1 Yr. Growth %	12.14	4.16	10.31	3.27	17.43
EBIT, 1 Yr. Growth %	11.31	3.82	9.98	3.27	17.32
Earnings From Cont. Operations, 1 Yr. Growth %	13.76	5.16	11.39	-43.54	-37.79
Net Income, 1 Yr. Growth %	15.97	1.7	-11.94	-107.47	-158.67
Normalized Net Income, 1 Yr. Growth %	20.62	-5.61	5.22	-33.56	9.86
Diluted EPS Before Extra, 1 Yr. Growth %	15.9	7.28	3.21	-53.96	-31.18
Accounts Receivable, 1 Yr. Growth %	16.88	18.08	0.61	13.03	-16.04
Inventory, 1 Yr. Growth %	-21.77	13.01	0.07	-10.92	-7.52
Net Property, Plant and Equip., 1 Yr. Growth %	21.32	1.79	1.2	-0.86	-11.92
Total Assets, 1 Yr. Growth %	12.47	11.15	3.88	-1.52	2.16
Tangible Book Value, 1 Yr. Growth %	33.62	28.68	3.33	-5.83	-12.97
Common Equity, 1 Yr. Growth %	7.46	4	3.65	-8.99	-9.58
Cash From Operations, 1 Yr. Growth %	57.13	-23.54	85.87	-12.29	37.78
Capital Expenditures, 1 Yr. Growth %	16.9	14.53	0.68	3.28	21.5
Levered Free Cash Flow, 1 Yr. Growth %	-834.54	-128.49	-782.52	-74.39	-820.43
Unlevered Free Cash Flow, 1 Yr. Growth %	3.91T	-105.88	43.49T	-46.16	-176.67
Dividend Per Share, 1 Yr. Growth %	0	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.01	10.62	6.96	6.36	-1.67
Gross Profit, 2 Yr. CAGR %	12.67	10.42	9.12	7.48	-0.11
EBITDA, 2 Yr. CAGR %	5.71	6.22	6.39	4.49	0.09
EBITA, 2 Yr. CAGR %	17.43	7.68	7.01	6.57	2.77
EBIT, 2 Yr. CAGR %	17	7.5	6.86	6.57	2.73
Earnings From Cont. Operations, 2 Yr. CAGR %	49.91	9.37	8.23	-20.7	-50.93
Net Income, 2 Yr. CAGR %	71.61	8.6	-5.37	-74.35	-79.06
Normalized Net Income, 2 Yr. CAGR %	21.65	6.7	-0.34	-16.39	-26.69
Diluted EPS Before Extra, 2 Yr. CAGR %	51.58	11.51	5.23	-31.07	-56.5
Accounts Receivable, 2 Yr. CAGR %	7.3	17.48	8.99	-1.42	6.78
Inventory, 2 Yr. CAGR %	17.22	-5.98	6.34	-5.58	-9.24
Net Property, Plant and Equip., 2 Yr. CAGR %	36.4	11.13	1.5	0.17	-6.55
Total Assets, 2 Yr. CAGR %	19.93	11.81	7.45	1.14	0.3
Tangible Book Value, 2 Yr. CAGR %	9.02	31.13	15.31	-1.36	-9.47
Common Equity, 2 Yr. CAGR %	13.2	5.72	3.83	-2.87	-9.28
Cash From Operations, 2 Yr. CAGR %	10.4	9.61	19.21	27.68	-1.84
Capital Expenditures, 2 Yr. CAGR %	16.33	15.71	7.38	1.97	5.84
Levered Free Cash Flow, 2 Yr. CAGR %	-0.51	44.67	20	29.25	-6.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	0.88	53.57	22.76	1.4T	-42.87
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	15.39	11.73	9.9	6.06	1.6
Gross Profit, 3 Yr. CAGR %	14.78	11.59	9.87	8.14	2.77
EBITDA, 3 Yr. CAGR %	12.85	5.78	7.3	6.06	1.48
EBITA, 3 Yr. CAGR %	25.08	12.56	8.43	5.65	5.12
EBIT, 3 Yr. CAGR %	24.78	12.43	8.32	5.65	5.09
Earnings From Cont. Operations, 3 Yr. CAGR %	24.13	33.2	10.04	-12.88	-35.51
Net Income, 3 Yr. CAGR %	23.4	44.14	1.27	-59.4	-66.21
Normalized Net Income, 3 Yr. CAGR %	32.37	11.79	6.21	-12.94	-17.31
Diluted EPS Before Extra, 3 Yr. CAGR %	23.23	35.08	8.67	-20.12	-41.98
Accounts Receivable, 3 Yr. CAGR %	6.72	10.78	11.56	4.7	-0.66
Inventory, 3 Yr. CAGR %	9.94	15.8	-4	0.25	-6.23
Net Property, Plant and Equip., 3 Yr. CAGR %	22.69	23.72	7.72	0.71	-4.04
Total Assets, 3 Yr. CAGR %	14.02	16.93	9.1	4.37	1.48
Tangible Book Value, 3 Yr. CAGR %	14.99	15.21	21.11	7.78	-5.39
Common Equity, 3 Yr. CAGR %	6.83	10.05	5.02	-0.63	-5.16
Cash From Operations, 3 Yr. CAGR %	13.84	-2.33	30.71	7.62	21.44
Capital Expenditures, 3 Yr. CAGR %	6.71	15.73	10.47	6	4.09
Levered Free Cash Flow, 3 Yr. CAGR %	42.01	-34.42	119.51	-29.36	79.18
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.44	-60.89	292.46	-7.85	415.82
Dividend Per Share, 3 Yr. CAGR %	1.27	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	18.28	16.51	11.94	9.55	5.12
Gross Profit, 5 Yr. CAGR %	17.6	16.55	12.48	9.93	5.77
EBITDA, 5 Yr. CAGR %	15.19	15.63	10.76	6.44	4.5
EBITA, 5 Yr. CAGR %	22.32	26.83	17.34	10.05	6.07
EBIT, 5 Yr. CAGR %	22.14	26.75	17.27	10.05	6.05
Earnings From Cont. Operations, 5 Yr. CAGR %	14.73	22.32	17.51	8.25	-20.33
Net Income, 5 Yr. CAGR %	13.37	20.32	10.97	-27.74	-46.09
Normalized Net Income, 5 Yr. CAGR %	18.72	25.5	18.16	-0.47	-8.43
Diluted EPS Before Extra, 5 Yr. CAGR %	13.3	21.55	15.68	3.21	-24.65
Accounts Receivable, 5 Yr. CAGR %	15.88	13.13	7.63	5.73	6.23
Inventory, 5 Yr. CAGR %	13.74	12.42	8.49	6.72	-6.13
Net Property, Plant and Equip., 5 Yr. CAGR %	23.64	20.72	13.73	13.7	1.76
Total Assets, 5 Yr. CAGR %	24.73	19.67	11.35	10.34	5.49
Tangible Book Value, 5 Yr. CAGR %	27.85	62.52	15.12	8.27	7.8
Common Equity, 5 Yr. CAGR %	6.71	6.43	5.62	4.69	-0.95
Cash From Operations, 5 Yr. CAGR %	18.68	16.52	15.96	8.72	16.56
Capital Expenditures, 5 Yr. CAGR %	15.49	14.53	6.98	10.02	8.59
Levered Free Cash Flow, 5 Yr. CAGR %	36	128.37	32.76	-18.99	54.89
Unlevered Free Cash Flow, 5 Yr. CAGR %	35.69	3.33	31.37	-4.45	80.26
Dividend Per Share, 5 Yr. CAGR %	0.76	-	-	-	-